Binding Sites are compared using Shaper.
For more information, please see the following publication:
Desaphy J. et al. Comparison and Druggability Prediction of protein-Ligand Binding sites from pharmacophore-annotated cavity shapes J. Chem. Inf. Model., 2012, 52(8), pp2287-2299
Binding Sites are considered as similar when the similarity value is greater than 0.44
| PDB ID | HET | Uniprot Name | EC Number |
|---|---|---|---|
| 1u54 | ACP | Activated CDC42 kinase 1 |
| PDB ID | HET | Uniprot Name | EC Number | Binding Site Similarity |
Align |
|---|---|---|---|---|---|
| 1u54 | ACP | Activated CDC42 kinase 1 | / | 1.000 | |
| 4riy | ADP | Epidermal growth factor receptor | 2.7.10.1 | 0.559 | |
| 1ad5 | ANP | Tyrosine-protein kinase HCK | 2.7.10.2 | 0.542 | |
| 2h8h | H8H | Proto-oncogene tyrosine-protein kinase Src | 2.7.10.2 | 0.534 | |
| 3cbl | STU | Tyrosine-protein kinase Fes/Fps | 2.7.10.2 | 0.533 | |
| 3vs2 | VSB | Tyrosine-protein kinase HCK | 2.7.10.2 | 0.530 | |
| 1qpj | STU | Tyrosine-protein kinase Lck | 2.7.10.2 | 0.529 | |
| 1u4d | DBQ | Activated CDC42 kinase 1 | / | 0.527 | |
| 5cnn | ANP | Epidermal growth factor receptor | 2.7.10.1 | 0.527 | |
| 3zew | STU | Ephrin type-B receptor 4 | 2.7.10.1 | 0.525 | |
| 2dq7 | STU | Tyrosine-protein kinase Fyn | 2.7.10.2 | 0.524 | |
| 2phk | ATP | Phosphorylase b kinase gamma catalytic chain, skeletal muscle/heart isoform | 2.7.11.19 | 0.521 | |
| 3vs7 | KS1 | Tyrosine-protein kinase HCK | 2.7.10.2 | 0.519 | |
| 1byg | STU | Tyrosine-protein kinase CSK | / | 0.518 | |
| 2qoq | ANP | Ephrin type-A receptor 3 | 2.7.10.1 | 0.516 | |
| 3cd3 | STU | Tyrosine-protein kinase Fes/Fps | 2.7.10.2 | 0.515 | |
| 4bf2 | STU | Mitogen-activated protein kinase kinase kinase 5 | 2.7.11.25 | 0.515 | |
| 1xr1 | ANP | Serine/threonine-protein kinase pim-1 | 2.7.11.1 | 0.512 | |
| 4oa9 | ANP | Protein BRASSINOSTEROID INSENSITIVE 1 | 2.7.10.1 | 0.512 | |
| 2xa4 | AZ5 | Tyrosine-protein kinase JAK2 | / | 0.511 | |
| 5e8w | STU | TGF-beta receptor type-1 | 2.7.11.30 | 0.510 | |
| 4k11 | 0J9 | Proto-oncogene tyrosine-protein kinase Src | 2.7.10.2 | 0.509 | |
| 3vs5 | VSG | Tyrosine-protein kinase HCK | 2.7.10.2 | 0.508 | |
| 5e8x | STU | TGF-beta receptor type-1 | 2.7.11.30 | 0.508 | |
| 4gk3 | L87 | Ephrin type-A receptor 3 | 2.7.10.1 | 0.506 | |
| 1eh4 | IC1 | Casein kinase I homolog 1 | 2.7.11.1 | 0.504 | |
| 3c50 | ADP | Rhodopsin kinase | / | 0.503 | |
| 5cno | ANP | Epidermal growth factor receptor | 2.7.10.1 | 0.502 | |
| 2clq | STU | Mitogen-activated protein kinase kinase kinase 5 | 2.7.11.25 | 0.501 | |
| 2xvd | AS6 | Ephrin type-B receptor 4 | 2.7.10.1 | 0.500 | |
| 3v5j | 0F2 | Tyrosine-protein kinase ITK/TSK | 2.7.10.2 | 0.499 | |
| 4fr4 | STU | Serine/threonine-protein kinase 32A | 2.7.11.1 | 0.498 | |
| 4y95 | 746 | Tyrosine-protein kinase | / | 0.498 | |
| 1qpd | STU | Tyrosine-protein kinase Lck | 2.7.10.2 | 0.497 | |
| 2hy8 | 1ST | Serine/threonine-protein kinase PAK 1 | 2.7.11.1 | 0.497 | |
| 2qo9 | ANP | Ephrin type-A receptor 3 | 2.7.10.1 | 0.496 | |
| 3vs4 | VSF | Tyrosine-protein kinase HCK | 2.7.10.2 | 0.496 | |
| 4i22 | IRE | Epidermal growth factor receptor | 2.7.10.1 | 0.496 | |
| 4y93 | 746 | Tyrosine-protein kinase | / | 0.496 | |
| 1yol | S03 | Proto-oncogene tyrosine-protein kinase Src | 2.7.10.2 | 0.495 | |
| 4ewh | T77 | Activated CDC42 kinase 1 | / | 0.495 | |
| 3gxl | QIG | TGF-beta receptor type-1 | 2.7.11.30 | 0.494 | |
| 1qcf | PP1 | Tyrosine-protein kinase HCK | 2.7.10.2 | 0.493 | |
| 2b9i | ADP | Mitogen-activated protein kinase FUS3 | 2.7.11.24 | 0.493 | |
| 2bdf | 24A | Proto-oncogene tyrosine-protein kinase Src | 2.7.10.2 | 0.493 | |
| 2csn | CKI | Casein kinase I homolog 1 | 2.7.11.1 | 0.491 | |
| 3lcd | BDY | Macrophage colony-stimulating factor 1 receptor | 2.7.10.1 | 0.491 | |
| 1rw8 | 580 | TGF-beta receptor type-1 | 2.7.11.30 | 0.490 | |
| 2nru | T12 | Interleukin-1 receptor-associated kinase 4 | 2.7.11.1 | 0.490 | |
| 3bkb | STU | Tyrosine-protein kinase Fes/Fps | 2.7.10.2 | 0.490 | |
| 4gk2 | L66 | Ephrin type-A receptor 3 | 2.7.10.1 | 0.490 | |
| 4jia | 1K3 | Tyrosine-protein kinase JAK2 | / | 0.490 | |
| 2hen | ADP | Ephrin type-B receptor 2 | 2.7.10.1 | 0.489 | |
| 2p2h | 994 | Vascular endothelial growth factor receptor 2 | 2.7.10.1 | 0.489 | |
| 2yn8 | STU | Ephrin type-B receptor 4 | 2.7.10.1 | 0.489 | |
| 3nwx | KVS | Gag-Pol polyprotein | 3.4.23.16 | 0.489 | |
| 3w16 | P9J | Aurora kinase A | 2.7.11.1 | 0.489 | |
| 1xjd | STU | Protein kinase C theta type | 2.7.11.13 | 0.488 | |
| 2c0t | L3G | Tyrosine-protein kinase HCK | 2.7.10.2 | 0.488 | |
| 4id7 | 1G0 | Activated CDC42 kinase 1 | / | 0.488 | |
| 4wkq | IRE | Epidermal growth factor receptor | 2.7.10.1 | 0.488 | |
| 2itn | ANP | Epidermal growth factor receptor | 2.7.10.1 | 0.486 | |
| 3hrf | ATP | 3-phosphoinositide-dependent protein kinase 1 | 2.7.11.1 | 0.486 | |
| 3vs3 | VSE | Tyrosine-protein kinase HCK | 2.7.10.2 | 0.486 | |
| 2j0m | 4ST | Focal adhesion kinase 1 | 2.7.10.2 | 0.485 | |
| 3vs0 | VS0 | Tyrosine-protein kinase HCK | 2.7.10.2 | 0.485 | |
| 3vjo | ANP | Epidermal growth factor receptor | 2.7.10.1 | 0.484 | |
| 3zh8 | C58 | Protein kinase C iota type | 2.7.11.13 | 0.484 | |
| 4c62 | XWW | Tyrosine-protein kinase JAK2 | / | 0.484 | |
| 4fob | 0US | ALK tyrosine kinase receptor | 2.7.10.1 | 0.484 | |
| 4zse | ANP | Epidermal growth factor receptor | 2.7.10.1 | 0.484 | |
| 3pxk | PXK | Focal adhesion kinase 1 | 2.7.10.2 | 0.483 | |
| 4j97 | ACP | Fibroblast growth factor receptor 2 | / | 0.483 | |
| 5aab | VGH | ALK tyrosine kinase receptor | 2.7.10.1 | 0.483 | |
| 2gcd | STU | Serine/threonine-protein kinase TAO2 | 2.7.11.1 | 0.482 | |
| 3vry | B43 | Tyrosine-protein kinase HCK | 2.7.10.2 | 0.482 | |
| 3vs6 | VSH | Tyrosine-protein kinase HCK | 2.7.10.2 | 0.482 | |
| 4a06 | ATP | 3-phosphoinositide-dependent protein kinase 1 | 2.7.11.1 | 0.482 | |
| 1u5r | ATP | Serine/threonine-protein kinase TAO2 | 2.7.11.1 | 0.481 | |
| 3mdv | CL6 | Cholesterol 24-hydroxylase | / | 0.481 | |
| 3mtf | A3F | Activin receptor type-1 | 2.7.11.30 | 0.481 | |
| 3vrz | VRZ | Tyrosine-protein kinase HCK | 2.7.10.2 | 0.481 | |
| 4j99 | ACP | Fibroblast growth factor receptor 2 | / | 0.481 | |
| 1csn | ATP | Casein kinase I homolog 1 | 2.7.11.1 | 0.480 | |
| 4ks8 | B49 | Serine/threonine-protein kinase PAK 6 | 2.7.11.1 | 0.480 | |
| 4c57 | FEF | Cyclin-G-associated kinase | 2.7.11.1 | 0.479 | |
| 4hge | 15V | Tyrosine-protein kinase JAK2 | / | 0.479 | |
| 4jq8 | KJ8 | Epidermal growth factor receptor | 2.7.10.1 | 0.479 | |
| 2cdz | 23D | Serine/threonine-protein kinase PAK 4 | 2.7.11.1 | 0.478 | |
| 2py3 | ACP | Fibroblast growth factor receptor 2 | / | 0.478 | |
| 4jr3 | KJR | Epidermal growth factor receptor | 2.7.10.1 | 0.478 | |
| 4rqk | ATP | 3-phosphoinositide-dependent protein kinase 1 | 2.7.11.1 | 0.478 | |
| 3lct | ADP | ALK tyrosine kinase receptor | 2.7.10.1 | 0.477 | |
| 5aac | VGH | ALK tyrosine kinase receptor | 2.7.10.1 | 0.477 | |
| 5e92 | ANP | TGF-beta receptor type-2 | 2.7.11.30 | 0.477 | |
| 2etm | 7PY | Focal adhesion kinase 1 | 2.7.10.2 | 0.476 | |
| 2ivu | ZD6 | Proto-oncogene tyrosine-protein kinase receptor Ret | 2.7.10.1 | 0.476 | |
| 2nry | STU | Interleukin-1 receptor-associated kinase 4 | 2.7.11.1 | 0.476 | |
| 2wot | ZZG | TGF-beta receptor type-1 | 2.7.11.30 | 0.476 | |
| 3a99 | ANP | Serine/threonine-protein kinase pim-1 | 2.7.11.1 | 0.476 | |
| 3lmg | ANP | Receptor tyrosine-protein kinase erbB-3 | 2.7.10.1 | 0.476 | |
| 4aoj | V4Z | High affinity nerve growth factor receptor | 2.7.10.1 | 0.476 | |
| 4gk4 | L90 | Ephrin type-A receptor 3 | 2.7.10.1 | 0.476 | |
| 1stc | STU | cAMP-dependent protein kinase catalytic subunit alpha | 2.7.11.11 | 0.475 | |
| 3i4b | Z48 | Glycogen synthase kinase-3 beta | 2.7.11.26 | 0.475 | |
| 3w32 | W32 | Epidermal growth factor receptor | 2.7.10.1 | 0.475 | |
| 4xlv | ACP | Insulin receptor | 2.7.10.1 | 0.475 | |
| 4yzc | STU | Serine/threonine-protein kinase/endoribonuclease IRE1 | 2.7.11.1 | 0.475 | |
| 5aaa | VGH | ALK tyrosine kinase receptor | 2.7.10.1 | 0.475 | |
| 2hk5 | 1BM | Tyrosine-protein kinase HCK | 2.7.10.2 | 0.474 | |
| 2of4 | 979 | Tyrosine-protein kinase Lck | 2.7.10.2 | 0.474 | |
| 3c4z | ADP | Rhodopsin kinase | / | 0.474 | |
| 3t11 | 3T1 | Gag-Pol polyprotein | 3.4.23.16 | 0.474 | |
| 4c58 | 824 | Cyclin-G-associated kinase | 2.7.11.1 | 0.474 | |
| 4ct2 | ATP | 3-phosphoinositide-dependent protein kinase 1 | 2.7.11.1 | 0.474 | |
| 4qml | ANP | Serine/threonine-protein kinase 24 | 2.7.11.1 | 0.474 | |
| 2of2 | 547 | Tyrosine-protein kinase Lck | 2.7.10.2 | 0.473 | |
| 2x9f | X9F | Ephrin type-B receptor 4 | 2.7.10.1 | 0.473 | |
| 3vs1 | VSA | Tyrosine-protein kinase HCK | 2.7.10.2 | 0.473 | |
| 4riy | ANP | Receptor tyrosine-protein kinase erbB-3 | 2.7.10.1 | 0.473 | |
| 1wvx | BD4 | Death-associated protein kinase 1 | 2.7.11.1 | 0.472 | |
| 2zva | 1N1 | Tyrosine-protein kinase Lyn | 2.7.10.2 | 0.472 | |
| 4xx9 | ATP | 3-phosphoinositide-dependent protein kinase 1 | 2.7.11.1 | 0.472 | |
| 5dt3 | ATP | Aurora kinase A | 2.7.11.1 | 0.472 | |
| 5dt4 | ATP | Aurora kinase A | 2.7.11.1 | 0.472 | |
| 1vjy | 460 | TGF-beta receptor type-1 | 2.7.11.30 | 0.471 | |
| 2jkq | VG8 | Focal adhesion kinase 1 | 2.7.10.2 | 0.471 | |
| 2v7a | 627 | Tyrosine-protein kinase ABL1 | 2.7.10.2 | 0.471 | |
| 2w1g | L0G | Aurora kinase A | 2.7.11.1 | 0.471 | |
| 1q97 | ATP | Serine/threonine-protein kinase SKY1 | 2.7.11.1 | 0.470 | |
| 4fod | 0UV | ALK tyrosine kinase receptor | 2.7.10.1 | 0.470 | |
| 4fti | H7K | Serine/threonine-protein kinase Chk1 | 2.7.11.1 | 0.470 | |
| 4g16 | 0VM | Casein kinase I isoform gamma-3 | 2.7.11.1 | 0.470 | |
| 4j95 | ACP | Fibroblast growth factor receptor 2 | / | 0.470 | |
| 4o0r | X4Z | Serine/threonine-protein kinase PAK 1 | 2.7.11.1 | 0.470 | |
| 1ol5 | ADP | Aurora kinase A | 2.7.11.1 | 0.469 | |
| 3a4o | STU | Tyrosine-protein kinase Lyn | 2.7.10.2 | 0.469 | |
| 3sc1 | 3S1 | 3-phosphoinositide-dependent protein kinase 1 | 2.7.11.1 | 0.469 | |
| 3v5l | 0G1 | Tyrosine-protein kinase ITK/TSK | 2.7.10.2 | 0.469 | |
| 3v8w | 0G2 | Tyrosine-protein kinase ITK/TSK | 2.7.10.2 | 0.469 | |
| 4k33 | ACP | Fibroblast growth factor receptor 3 | 2.7.10.1 | 0.469 | |
| 1ir3 | ANP | Insulin receptor | 2.7.10.1 | 0.468 | |
| 2c0i | L1G | Tyrosine-protein kinase HCK | 2.7.10.2 | 0.468 | |
| 2vwu | 7X1 | Ephrin type-B receptor 4 | 2.7.10.1 | 0.468 | |
| 1yvj | 4ST | Tyrosine-protein kinase JAK3 | 2.7.10.2 | 0.467 | |
| 2ijm | ATP | Focal adhesion kinase 1 | 2.7.10.2 | 0.467 | |
| 3c4w | ATP | Rhodopsin kinase | / | 0.467 | |
| 3lpb | NVB | Tyrosine-protein kinase JAK2 | / | 0.467 | |
| 3poz | 03P | Epidermal growth factor receptor | 2.7.10.1 | 0.467 | |
| 3t8o | ATP | Rhodopsin kinase | / | 0.467 | |
| 4bb4 | 32W | Ephrin type-B receptor 4 | 2.7.10.1 | 0.467 | |
| 4bbe | 3O4 | Tyrosine-protein kinase JAK2 | / | 0.467 | |
| 4xey | 1N1 | Tyrosine-protein kinase ABL1 | 2.7.10.2 | 0.467 | |
| 1oky | STU | 3-phosphoinositide-dependent protein kinase 1 | 2.7.11.1 | 0.466 | |
| 2cke | IQU | Death-associated protein kinase 2 | / | 0.466 | |
| 3bgq | VX2 | Serine/threonine-protein kinase pim-1 | 2.7.11.1 | 0.466 | |
| 3q4z | ANP | Serine/threonine-protein kinase PAK 1 | 2.7.11.1 | 0.466 | |
| 4bib | IEO | Mitogen-activated protein kinase kinase kinase 5 | 2.7.11.25 | 0.466 | |
| 4cki | ADN | Proto-oncogene tyrosine-protein kinase receptor Ret | 2.7.10.1 | 0.466 | |
| 4ft7 | H3K | Serine/threonine-protein kinase Chk1 | 2.7.11.1 | 0.466 | |
| 4jr7 | GNP | Casein kinase II subunit alpha | 2.7.11.1 | 0.466 | |
| 1x8b | 824 | Wee1-like protein kinase | 2.7.10.2 | 0.465 | |
| 2biy | ATP | 3-phosphoinositide-dependent protein kinase 1 | 2.7.11.1 | 0.465 | |
| 2w1f | L0F | Aurora kinase A | 2.7.11.1 | 0.465 | |
| 3a7j | ADP | Serine/threonine-protein kinase 24 | 2.7.11.1 | 0.465 | |
| 3frq | ERY | Erythromycin resistance repressor protein | / | 0.465 | |
| 3le6 | 2BZ | Cyclin-dependent kinase 2 | 2.7.11.22 | 0.465 | |
| 4hvh | 19R | Tyrosine-protein kinase JAK3 | 2.7.10.2 | 0.465 | |
| 4k18 | 1OB | Serine/threonine-protein kinase pim-1 | 2.7.11.1 | 0.465 | |
| 1h1w | ATP | 3-phosphoinositide-dependent protein kinase 1 | 2.7.11.1 | 0.464 | |
| 1jpa | ANP | Ephrin type-B receptor 2 | 2.7.10.1 | 0.464 | |
| 2hck | QUE | Tyrosine-protein kinase HCK | 2.7.10.2 | 0.464 | |
| 3oom | 507 | Activin receptor type-1 | 2.7.11.30 | 0.464 | |
| 3ue4 | DB8 | Tyrosine-protein kinase ABL1 | 2.7.10.2 | 0.464 | |
| 4c61 | LMM | Tyrosine-protein kinase JAK2 | / | 0.464 | |
| 4fg7 | ATP | Calcium/calmodulin-dependent protein kinase type 1 | 2.7.11.17 | 0.464 | |
| 4fl1 | ANP | Tyrosine-protein kinase SYK | 2.7.10.2 | 0.464 | |
| 4yuq | KS1 | Calmodulin-like domain protein kinase | / | 0.464 | |
| 1zrz | BI1 | Protein kinase C iota type | 2.7.11.13 | 0.463 | |
| 2j0l | ANP | Focal adhesion kinase 1 | 2.7.10.2 | 0.463 | |
| 2vx1 | 7X8 | Ephrin type-B receptor 4 | 2.7.10.1 | 0.463 | |
| 4brx | KGW | Focal adhesion kinase 1 | 2.7.10.2 | 0.463 | |
| 5dr6 | SKE | Aurora kinase A | 2.7.11.1 | 0.463 | |
| 1okz | UCN | 3-phosphoinositide-dependent protein kinase 1 | 2.7.11.1 | 0.462 | |
| 1pkg | ADP | Mast/stem cell growth factor receptor Kit | 2.7.10.1 | 0.462 | |
| 1py5 | PY1 | TGF-beta receptor type-1 | 2.7.11.30 | 0.462 | |
| 2pwl | ACP | Fibroblast growth factor receptor 2 | / | 0.462 | |
| 2vwz | 7X6 | Ephrin type-B receptor 4 | 2.7.10.1 | 0.462 | |
| 2xch | CKG | 3-phosphoinositide-dependent protein kinase 1 | 2.7.11.1 | 0.462 | |
| 3a62 | STU | Ribosomal protein S6 kinase beta-1 | 2.7.11.1 | 0.462 | |
| 4enx | Z20 | Serine/threonine-protein kinase pim-1 | 2.7.11.1 | 0.462 | |
| 4eut | BX7 | Serine/threonine-protein kinase TBK1 | 2.7.11.1 | 0.462 | |
| 4hvi | 19S | Tyrosine-protein kinase JAK3 | 2.7.10.2 | 0.462 | |
| 4i23 | 1C9 | Epidermal growth factor receptor | 2.7.10.1 | 0.462 | |
| 4iwo | 1H4 | Serine/threonine-protein kinase TBK1 | 2.7.11.1 | 0.462 | |
| 4ix6 | ADP | Uncharacterized protein | / | 0.462 | |
| 4l7s | G7K | Tyrosine-protein kinase ITK/TSK | 2.7.10.2 | 0.462 | |
| 5cvh | ADP | Casein kinase II subunit alpha | 2.7.11.1 | 0.462 | |
| 2bdj | HET | Proto-oncogene tyrosine-protein kinase Src | 2.7.10.2 | 0.461 | |
| 2itq | ITQ | Epidermal growth factor receptor | 2.7.10.1 | 0.461 | |
| 3hmm | 855 | TGF-beta receptor type-1 | 2.7.11.30 | 0.461 | |
| 4otp | ADP | Serine/threonine-protein kinase RIO1 | 2.7.11.1 | 0.461 | |
| 5ack | ATP | 3-phosphoinositide-dependent protein kinase 1 | 2.7.11.1 | 0.461 | |
| 1j1c | ADP | Glycogen synthase kinase-3 beta | 2.7.11.26 | 0.460 | |
| 2acx | ANP | G protein-coupled receptor kinase 6 | 2.7.11.16 | 0.460 | |
| 2np8 | CC3 | Aurora kinase A | 2.7.11.1 | 0.460 | |
| 3nwq | 2NC | Gag-Pol polyprotein | 3.4.23.16 | 0.460 | |
| 3qd4 | 3Q6 | 3-phosphoinositide-dependent protein kinase 1 | 2.7.11.1 | 0.460 | |
| 3w2s | W2R | Epidermal growth factor receptor | 2.7.10.1 | 0.460 | |
| 4c02 | TAK | Activin receptor type-1 | 2.7.11.30 | 0.460 | |
| 4gmy | 0X5 | Tyrosine-protein kinase JAK2 | / | 0.460 | |
| 4jbo | WPH | Aurora kinase A | 2.7.11.1 | 0.460 | |
| 4nks | 2M2 | Fibroblast growth factor receptor 1 | / | 0.460 | |
| 5dn3 | ATP | Aurora kinase A | 2.7.11.1 | 0.460 | |
| 2c0o | L2G | Tyrosine-protein kinase HCK | 2.7.10.2 | 0.459 | |
| 2qo7 | ANP | Ephrin type-A receptor 3 | 2.7.10.1 | 0.459 | |
| 2xb7 | GUI | ALK tyrosine kinase receptor | 2.7.10.1 | 0.459 | |
| 2xp2 | VGH | ALK tyrosine kinase receptor | 2.7.10.1 | 0.459 | |
| 2y6o | 1N1 | Ephrin type-A receptor 4 | 2.7.10.1 | 0.459 | |
| 3qd0 | 3Q4 | 3-phosphoinositide-dependent protein kinase 1 | 2.7.11.1 | 0.459 | |
| 3qd3 | 3Q5 | 3-phosphoinositide-dependent protein kinase 1 | 2.7.11.1 | 0.459 | |
| 4ix5 | ANP | Uncharacterized protein | / | 0.459 | |
| 4o0w | ADN | Aurora kinase A | 2.7.11.1 | 0.459 | |
| 1y57 | MPZ | Proto-oncogene tyrosine-protein kinase Src | 2.7.10.2 | 0.458 | |
| 3mfu | ANP | Peripheral plasma membrane protein CASK | 2.7.11.1 | 0.458 | |
| 4anx | 534 | Phosphatidylinositol 4,5-bisphosphate 3-kinase catalytic subunit gamma isoform | 2.7.1.153 | 0.458 | |
| 4bbf | O19 | Tyrosine-protein kinase JAK2 | / | 0.458 | |
| 4dn5 | AGS | Mitogen-activated protein kinase kinase kinase 14 | 2.7.11.25 | 0.458 | |
| 4f08 | 1RS | Tyrosine-protein kinase JAK2 | / | 0.458 | |
| 4hvg | 19Q | Tyrosine-protein kinase JAK3 | 2.7.10.2 | 0.458 | |
| 4kio | G5K | Tyrosine-protein kinase ITK/TSK | 2.7.10.2 | 0.458 | |
| 2gdo | 12C | Serine/threonine-protein kinase Chk1 | 2.7.11.1 | 0.457 | |
| 2r7b | 253 | 3-phosphoinositide-dependent protein kinase 1 | 2.7.11.1 | 0.457 | |
| 3cr0 | 809 | Wee1-like protein kinase | 2.7.10.2 | 0.457 | |
| 3iok | 1P6 | Tyrosine-protein kinase JAK2 | / | 0.457 | |
| 3qcq | 3Q0 | 3-phosphoinositide-dependent protein kinase 1 | 2.7.11.1 | 0.457 | |
| 3w33 | W19 | Epidermal growth factor receptor | 2.7.10.1 | 0.457 | |
| 4cd0 | AWJ | ALK tyrosine kinase receptor | 2.7.10.1 | 0.457 | |
| 4ct1 | ATP | 3-phosphoinositide-dependent protein kinase 1 | 2.7.11.1 | 0.457 | |
| 4fsn | A58 | Serine/threonine-protein kinase Chk1 | 2.7.11.1 | 0.457 | |
| 4c3f | 7KW | Tyrosine-protein kinase Lck | 2.7.10.2 | 0.456 | |
| 1aq1 | STU | Cyclin-dependent kinase 2 | 2.7.11.22 | 0.455 | |
| 1ol7 | ADP | Aurora kinase A | 2.7.11.1 | 0.455 | |
| 1phk | ATP | Phosphorylase b kinase gamma catalytic chain, skeletal muscle/heart isoform | 2.7.11.19 | 0.455 | |
| 1pmn | 984 | Mitogen-activated protein kinase 10 | 2.7.11.24 | 0.455 | |
| 2b9f | ADP | Mitogen-activated protein kinase FUS3 | 2.7.11.24 | 0.455 | |
| 2eb3 | ANP | Epidermal growth factor receptor | 2.7.10.1 | 0.455 | |
| 2vd5 | BI8 | Myotonin-protein kinase | 2.7.11.1 | 0.455 | |
| 2vww | 7X2 | Ephrin type-B receptor 4 | 2.7.10.1 | 0.455 | |
| 2vx0 | 7X7 | Ephrin type-B receptor 4 | 2.7.10.1 | 0.455 | |
| 2ym6 | YM6 | Serine/threonine-protein kinase Chk1 | 2.7.11.1 | 0.455 | |
| 3apf | BMW | Phosphatidylinositol 4,5-bisphosphate 3-kinase catalytic subunit gamma isoform | 2.7.1.153 | 0.455 | |
| 3bu5 | ATP | Insulin receptor | 2.7.10.1 | 0.455 | |
| 4anq | VGH | ALK tyrosine kinase receptor | 2.7.10.1 | 0.455 | |
| 4aqc | 88A | Tyrosine-protein kinase JAK2 | / | 0.455 | |
| 4ft0 | HK9 | Serine/threonine-protein kinase Chk1 | 2.7.11.1 | 0.455 | |
| 4jq7 | KJQ | Epidermal growth factor receptor | 2.7.10.1 | 0.455 | |
| 4kb8 | 1QO | Casein kinase I isoform delta | 2.7.11.1 | 0.455 | |
| 4xli | 1N1 | Abelson tyrosine-protein kinase 2 | 2.7.10.2 | 0.455 | |
| 4yr9 | NAD | L-threonine 3-dehydrogenase, mitochondrial | 1.1.1.103 | 0.455 | |
| 5drd | ATP | Aurora kinase A | 2.7.11.1 | 0.455 | |
| 2gs7 | ANP | Epidermal growth factor receptor | 2.7.10.1 | 0.454 | |
| 2vgo | AD5 | Aurora kinase B-A | 2.7.11.1 | 0.454 | |
| 2xck | MH4 | 3-phosphoinositide-dependent protein kinase 1 | 2.7.11.1 | 0.454 | |
| 3d7t | STU | Tyrosine-protein kinase CSK | / | 0.454 | |
| 3f7z | 34O | Glycogen synthase kinase-3 beta | 2.7.11.26 | 0.454 | |
| 3k5u | PFQ | Aurora kinase A | 2.7.11.1 | 0.454 | |
| 3nsz | ANP | Casein kinase II subunit alpha | 2.7.11.1 | 0.454 | |
| 3nun | JMZ | 3-phosphoinositide-dependent protein kinase 1 | 2.7.11.1 | 0.454 | |
| 4bkz | 1WS | Maternal embryonic leucine zipper kinase | 2.7.11.1 | 0.454 | |
| 4ful | 0VU | Phosphatidylinositol 4,5-bisphosphate 3-kinase catalytic subunit gamma isoform | 2.7.1.153 | 0.454 | |
| 4g2f | C07 | Ephrin type-A receptor 3 | 2.7.10.1 | 0.454 | |
| 5dnr | ATP | Aurora kinase A | 2.7.11.1 | 0.454 | |
| 1kbq | FAD | NAD(P)H dehydrogenase [quinone] 1 | 1.6.5.2 | 0.453 | |
| 1ny3 | ADP | MAP kinase-activated protein kinase 2 | 2.7.11.1 | 0.453 | |
| 1om1 | IQA | Casein kinase II subunit alpha | 2.7.11.1 | 0.453 | |
| 2cmw | OLP | Casein kinase I isoform gamma-1 | 2.7.11.1 | 0.453 | |
| 2xik | J60 | Serine/threonine-protein kinase 25 | 2.7.11.1 | 0.453 | |
| 3c4x | ATP | Rhodopsin kinase | / | 0.453 | |
| 3dds | 26B | Glycogen phosphorylase, liver form | 2.4.1.1 | 0.453 | |
| 3efw | AK8 | Aurora kinase A | 2.7.11.1 | 0.453 | |
| 3ggf | GVD | Serine/threonine-protein kinase 26 | / | 0.453 | |
| 3gu7 | ADP | Death-associated protein kinase 1 | 2.7.11.1 | 0.453 | |
| 3r2b | 05B | MAP kinase-activated protein kinase 2 | 2.7.11.1 | 0.453 | |
| 3w0s | ANP | Hygromycin-B 4-O-kinase | 2.7.1.163 | 0.453 | |
| 4c34 | STU | cAMP-dependent protein kinase catalytic subunit alpha | 2.7.11.11 | 0.453 | |
| 4dee | ADP | Aurora kinase A | 2.7.11.1 | 0.453 | |
| 4fsr | HKC | Serine/threonine-protein kinase Chk1 | 2.7.11.1 | 0.453 | |
| 4fv1 | EK4 | Mitogen-activated protein kinase 1 | 2.7.11.24 | 0.453 | |
| 4gdy | 0X1 | Kynurenine/alpha-aminoadipate aminotransferase, mitochondrial | 2.6.1.39 | 0.453 | |
| 4ji9 | 1M3 | Tyrosine-protein kinase JAK2 | / | 0.453 | |
| 4u97 | STU | Interleukin-1 receptor-associated kinase 4 | 2.7.11.1 | 0.453 | |
| 4u9a | STU | Interleukin-1 receptor-associated kinase 4 | 2.7.11.1 | 0.453 | |
| 5e8y | STU | TGF-beta receptor type-2 | 2.7.11.30 | 0.453 | |
| 1bws | NDP | GDP-L-fucose synthase | / | 0.452 | |
| 1xl2 | 189 | Gag-Pol polyprotein | 3.4.23.16 | 0.452 | |
| 2itv | ANP | Epidermal growth factor receptor | 2.7.10.1 | 0.452 | |
| 2vwy | 7X5 | Ephrin type-B receptor 4 | 2.7.10.1 | 0.452 | |
| 2x1n | X1N | Cyclin-dependent kinase 2 | 2.7.11.22 | 0.452 | |
| 2xbj | XBJ | Serine/threonine-protein kinase Chk2 | 2.7.11.1 | 0.452 | |
| 3b8r | 887 | Vascular endothelial growth factor receptor 2 | 2.7.10.1 | 0.452 | |
| 3elj | GS7 | Mitogen-activated protein kinase 8 | 2.7.11.24 | 0.452 | |
| 3vid | 4TT | Vascular endothelial growth factor receptor 2 | 2.7.10.1 | 0.452 | |
| 4bid | IE8 | Mitogen-activated protein kinase kinase kinase 5 | 2.7.11.25 | 0.452 | |
| 4iwq | 1FV | Serine/threonine-protein kinase TBK1 | 2.7.11.1 | 0.452 | |
| 4mxx | DB8 | Proto-oncogene tyrosine-protein kinase Src | 2.7.10.2 | 0.452 | |
| 5a4k | FAD | NAD(P)H dehydrogenase [quinone] 1 | 1.6.5.2 | 0.452 | |
| 1h66 | FAD | NAD(P)H dehydrogenase [quinone] 1 | 1.6.5.2 | 0.451 | |
| 1m17 | AQ4 | Epidermal growth factor receptor | 2.7.10.1 | 0.451 | |
| 1m2r | MNY | Casein kinase II subunit alpha | 2.7.11.1 | 0.451 | |
| 2izr | BRK | Casein kinase I isoform gamma-3 | 2.7.11.1 | 0.451 | |
| 2vwx | 7X4 | Ephrin type-B receptor 4 | 2.7.10.1 | 0.451 | |
| 3ac1 | KZI | Tyrosine-protein kinase Lck | 2.7.10.2 | 0.451 | |
| 3oro | AGS | Serine/threonine protein kinase | / | 0.451 | |
| 4ftr | 5HK | Serine/threonine-protein kinase Chk1 | 2.7.11.1 | 0.451 | |
| 4l9i | 8PR | Rhodopsin kinase | / | 0.451 | |
| 4o0s | ADN | Aurora kinase A | 2.7.11.1 | 0.451 | |
| 4rrv | ATP | 3-phosphoinositide-dependent protein kinase 1 | 2.7.11.1 | 0.451 | |
| 1nzd | UPG | DNA beta-glucosyltransferase | / | 0.450 | |
| 1zth | ADP | RIO-type serine/threonine-protein kinase Rio1 | 2.7.11.1 | 0.450 | |
| 2b7a | IZA | Tyrosine-protein kinase JAK2 | / | 0.450 | |
| 2pe2 | 464 | 3-phosphoinositide-dependent protein kinase 1 | 2.7.11.1 | 0.450 | |
| 2vu3 | LZE | Cyclin-dependent kinase 2 | 2.7.11.22 | 0.450 | |
| 3bhe | BZN | Gag-Pol polyprotein | 3.4.23.16 | 0.450 | |
| 3gub | GUB | Death-associated protein kinase 1 | 2.7.11.1 | 0.450 | |
| 3hrc | ATP | 3-phosphoinositide-dependent protein kinase 1 | 2.7.11.1 | 0.450 | |
| 3rwp | ABQ | 3-phosphoinositide-dependent protein kinase 1 | 2.7.11.1 | 0.450 | |
| 3she | I85 | MAP kinase-activated protein kinase 3 | 2.7.11.1 | 0.450 | |
| 4e20 | 0MY | Non-receptor tyrosine-protein kinase TYK2 | 2.7.10.2 | 0.450 | |
| 4k8a | K8A | Focal adhesion kinase 1 | 2.7.10.2 | 0.450 | |
| 4tuv | CPZ | Cytochrome P450 119 | 1.14 | 0.450 | |
| 5ar4 | SB2 | Receptor-interacting serine/threonine-protein kinase 2 | 2.7.11.1 | 0.450 | |
| 1u59 | STU | Tyrosine-protein kinase ZAP-70 | 2.7.10.2 | 0.449 | |
| 1xdd | AAY | Integrin alpha-L | / | 0.449 | |
| 3cjg | KIM | Vascular endothelial growth factor receptor 2 | 2.7.10.1 | 0.449 | |
| 3qcs | 3Q1 | 3-phosphoinositide-dependent protein kinase 1 | 2.7.11.1 | 0.449 | |
| 3rvg | 17P | Tyrosine-protein kinase JAK2 | / | 0.449 | |
| 4anv | 751 | Phosphatidylinositol 4,5-bisphosphate 3-kinase catalytic subunit gamma isoform | 2.7.1.153 | 0.449 | |
| 4anw | O92 | Phosphatidylinositol 4,5-bisphosphate 3-kinase catalytic subunit gamma isoform | 2.7.1.153 | 0.449 | |
| 4enh | FVX | Cholesterol 24-hydroxylase | / | 0.449 | |
| 4ftu | 7HK | Serine/threonine-protein kinase Chk1 | 2.7.11.1 | 0.449 | |
| 4qny | ANP | Mitogen activated protein kinase, putative | / | 0.449 | |
| 4wbo | ANW | Rhodopsin kinase | / | 0.449 | |
| 2i0y | 5CN | Macrophage colony-stimulating factor 1 receptor | 2.7.10.1 | 0.448 | |
| 2q61 | SF1 | Peroxisome proliferator-activated receptor gamma | / | 0.448 | |
| 2wmr | ZYR | Serine/threonine-protein kinase Chk1 | 2.7.11.1 | 0.448 | |
| 2x3n | FAD | Probable FAD-dependent monooxygenase | / | 0.448 | |
| 3f69 | XDR | Serine/threonine-protein kinase PknB | 2.7.11.1 | 0.448 | |
| 3gc9 | B45 | Mitogen-activated protein kinase 11 | 2.7.11.24 | 0.448 | |
| 3mfs | ANP | Peripheral plasma membrane protein CASK | 2.7.11.1 | 0.448 | |
| 3qaq | QAQ | Phosphatidylinositol 4,5-bisphosphate 3-kinase catalytic subunit gamma isoform | 2.7.1.153 | 0.448 | |
| 4ans | VGH | ALK tyrosine kinase receptor | 2.7.10.1 | 0.448 | |
| 4aot | GW8 | Serine/threonine-protein kinase 10 | 2.7.11.1 | 0.448 | |
| 4dtk | 7LI | Serine/threonine-protein kinase pim-1 | 2.7.11.1 | 0.448 | |
| 4erw | STU | Cyclin-dependent kinase 2 | 2.7.11.22 | 0.448 | |
| 4gii | 0X6 | Non-receptor tyrosine-protein kinase TYK2 | 2.7.10.2 | 0.448 | |
| 4hle | 17V | Phosphatidylinositol 4,5-bisphosphate 3-kinase catalytic subunit gamma isoform | 2.7.1.153 | 0.448 | |
| 4im2 | BX7 | Serine/threonine-protein kinase TBK1 | 2.7.11.1 | 0.448 | |
| 4q71 | FAD | Bifunctional protein PutA | / | 0.448 | |
| 4utd | ACP | Aurora kinase A | 2.7.11.1 | 0.448 | |
| 5l8l | ADP | Aurora kinase A | 2.7.11.1 | 0.448 | |
| 1nqo | NAD | Glyceraldehyde-3-phosphate dehydrogenase | / | 0.447 | |
| 1nvq | UCN | Serine/threonine-protein kinase Chk1 | 2.7.11.1 | 0.447 | |
| 1zp9 | ATP | RIO-type serine/threonine-protein kinase Rio1 | 2.7.11.1 | 0.447 | |
| 2cgu | 3A3 | Serine/threonine-protein kinase Chk1 | 2.7.11.1 | 0.447 | |
| 2cgw | 3C3 | Serine/threonine-protein kinase Chk1 | 2.7.11.1 | 0.447 | |
| 2pe1 | 517 | 3-phosphoinositide-dependent protein kinase 1 | 2.7.11.1 | 0.447 | |
| 3nyn | SGV | G protein-coupled receptor kinase 6 | 2.7.11.16 | 0.447 | |
| 4e4m | 0NH | Tyrosine-protein kinase JAK2 | / | 0.447 | |
| 4hgl | 0YO | Casein kinase I isoform gamma-3 | 2.7.11.1 | 0.447 | |
| 4im0 | 1FV | Serine/threonine-protein kinase TBK1 | 2.7.11.1 | 0.447 | |
| 4iva | 1J5 | Tyrosine-protein kinase JAK2 | / | 0.447 | |
| 4qmt | H1N | Serine/threonine-protein kinase 24 | 2.7.11.1 | 0.447 | |
| 4r8q | ADP | Mitotic checkpoint serine/threonine-protein kinase BUB1 | 2.7.11.1 | 0.447 | |
| 2e9u | A25 | Serine/threonine-protein kinase Chk1 | 2.7.11.1 | 0.446 | |
| 2hog | 710 | Serine/threonine-protein kinase Chk1 | 2.7.11.1 | 0.446 | |
| 2qoc | ANP | Ephrin type-A receptor 3 | 2.7.10.1 | 0.446 | |
| 3ork | AGS | Serine/threonine protein kinase | / | 0.446 | |
| 3s4q | NK0 | Mitogen-activated protein kinase 14 | / | 0.446 | |
| 3zze | 6XP | Hepatocyte growth factor receptor | 2.7.10.1 | 0.446 | |
| 4aw0 | ATP | 3-phosphoinositide-dependent protein kinase 1 | 2.7.11.1 | 0.446 | |
| 4ccb | OFG | ALK tyrosine kinase receptor | 2.7.10.1 | 0.446 | |
| 4fl3 | ANP | Tyrosine-protein kinase SYK | 2.7.10.2 | 0.446 | |
| 4fsw | HK6 | Serine/threonine-protein kinase Chk1 | 2.7.11.1 | 0.446 | |
| 4hgs | 15G | Casein kinase I isoform gamma-3 | 2.7.11.1 | 0.446 | |
| 4yhj | AN2 | G protein-coupled receptor kinase 4 | 2.7.11.16 | 0.446 | |
| 1e7v | LY2 | Phosphatidylinositol 4,5-bisphosphate 3-kinase catalytic subunit gamma isoform | 2.7.1.153 | 0.445 | |
| 1kbo | FAD | NAD(P)H dehydrogenase [quinone] 1 | 1.6.5.2 | 0.445 | |
| 1pyx | ANP | Glycogen synthase kinase-3 beta | 2.7.11.26 | 0.445 | |
| 2exc | JNK | Mitogen-activated protein kinase 10 | 2.7.11.24 | 0.445 | |
| 2izu | P01 | Casein kinase I isoform gamma-3 | 2.7.11.1 | 0.445 | |
| 2vz6 | FEF | Calcium/calmodulin-dependent protein kinase type II subunit alpha | 2.7.11.17 | 0.445 | |
| 2yfx | VGH | ALK tyrosine kinase receptor | 2.7.10.1 | 0.445 | |
| 3i60 | E86 | Mitogen-activated protein kinase 1 | 2.7.11.24 | 0.445 | |
| 3r04 | UNQ | Serine/threonine-protein kinase pim-1 | 2.7.11.1 | 0.445 | |
| 3zmm | F9J | Tyrosine-protein kinase JAK2 | / | 0.445 | |
| 4anm | WUL | Casein kinase II subunit alpha | 2.7.11.1 | 0.445 | |
| 5awm | ANP | Stress-activated protein kinase JNK | 2.7.11.24 | 0.445 | |
| 1k6p | XN3 | Gag-Pol polyprotein | 3.4.23.16 | 0.444 | |
| 1mqb | ANP | Ephrin type-A receptor 2 | 2.7.10.1 | 0.444 | |
| 1uye | PU9 | Heat shock protein HSP 90-alpha | / | 0.444 | |
| 2bfy | H1N | Aurora kinase B-A | 2.7.11.1 | 0.444 | |
| 2cgx | 3D3 | Serine/threonine-protein kinase Chk1 | 2.7.11.1 | 0.444 | |
| 2hxl | 422 | Serine/threonine-protein kinase Chk1 | 2.7.11.1 | 0.444 | |
| 2j2i | LY4 | Serine/threonine-protein kinase pim-1 | 2.7.11.1 | 0.444 | |
| 2wxv | WXV | Cyclin-dependent kinase 2 | 2.7.11.22 | 0.444 | |
| 2ydi | YDI | Serine/threonine-protein kinase Chk1 | 2.7.11.1 | 0.444 | |
| 2zm1 | KSF | Tyrosine-protein kinase Lck | 2.7.10.2 | 0.444 | |
| 3a1n | NAD | NDP-sugar epimerase | / | 0.444 | |
| 3et7 | 349 | Protein-tyrosine kinase 2-beta | 2.7.10.2 | 0.444 | |
| 3rm6 | 18Z | Cyclin-dependent kinase 2 | 2.7.11.22 | 0.444 | |
| 4c59 | FEF | Cyclin-G-associated kinase | 2.7.11.1 | 0.444 | |
| 4f63 | 0S7 | Fibroblast growth factor receptor 1 | / | 0.444 | |
| 4gg7 | 0J8 | Hepatocyte growth factor receptor | 2.7.10.1 | 0.444 | |
| 4jrv | KJV | Epidermal growth factor receptor | 2.7.10.1 | 0.444 | |
| 4krc | AGS | Cyclin-dependent protein kinase PHO85 | 2.7.11.22 | 0.444 | |
| 1uvr | BI8 | 3-phosphoinositide-dependent protein kinase 1 | 2.7.11.1 | 0.443 | |
| 2brb | PFQ | Serine/threonine-protein kinase Chk1 | 2.7.11.1 | 0.443 | |
| 2p33 | J07 | Mitogen-activated protein kinase 10 | 2.7.11.24 | 0.443 | |
| 2vn9 | GVD | Calcium/calmodulin-dependent protein kinase type II subunit delta | 2.7.11.17 | 0.443 | |
| 3a4p | DFQ | Hepatocyte growth factor receptor | 2.7.10.1 | 0.443 | |
| 3nxe | 2NC | Protease | / | 0.443 | |
| 4b0g | VEK | Aurora kinase A | 2.7.11.1 | 0.443 | |
| 4eoo | ATP | Cyclin-dependent kinase 2 | 2.7.11.22 | 0.443 | |
| 4fv3 | EK6 | Mitogen-activated protein kinase 1 | 2.7.11.24 | 0.443 | |
| 4fv5 | EK9 | Mitogen-activated protein kinase 1 | 2.7.11.24 | 0.443 | |
| 4mvf | STU | Calcium-dependent protein kinase 2 | 2.7.11.1 | 0.443 | |
| 4n70 | 2HX | Serine/threonine-protein kinase pim-1 | 2.7.11.1 | 0.443 | |
| 4qmy | STU | Serine/threonine-protein kinase 24 | 2.7.11.1 | 0.443 | |
| 5d12 | G97 | Proto-oncogene tyrosine-protein kinase Src | 2.7.10.2 | 0.443 | |
| 5dpv | SKE | Aurora kinase A | 2.7.11.1 | 0.443 | |
| 1nvs | UCM | Serine/threonine-protein kinase Chk1 | 2.7.11.1 | 0.442 | |
| 1pkd | UCN | Cyclin-dependent kinase 2 | 2.7.11.22 | 0.442 | |
| 2x4f | 16X | Myosin light chain kinase family member 4 | 2.7.11.1 | 0.442 | |
| 2xyu | Q9G | Ephrin type-A receptor 4 | 2.7.10.1 | 0.442 | |
| 2y46 | MIV | Mycinamicin IV hydroxylase/epoxidase | / | 0.442 | |
| 2yit | YIT | Serine/threonine-protein kinase Chk2 | 2.7.11.1 | 0.442 | |
| 3a7h | ATP | Serine/threonine-protein kinase 24 | 2.7.11.1 | 0.442 | |
| 3gwf | FAD | Cyclohexanone monooxygenase | / | 0.442 | |
| 4a7c | E46 | Serine/threonine-protein kinase pim-1 | 2.7.11.1 | 0.442 | |
| 4qgi | ROC | Gag-Pol polyprotein | 3.4.23.16 | 0.442 | |
| 1k6c | MK1 | Gag-Pol polyprotein | 3.4.23.16 | 0.441 | |
| 1mru | AGS | Serine/threonine-protein kinase PknB | 2.7.11.1 | 0.441 | |
| 1q8y | ADP | Serine/threonine-protein kinase SKY1 | 2.7.11.1 | 0.441 | |
| 2wip | P49 | Cyclin-dependent kinase 2 | 2.7.11.22 | 0.441 | |
| 2wmw | ZYW | Serine/threonine-protein kinase Chk1 | 2.7.11.1 | 0.441 | |
| 2wtc | VGM | Serine/threonine-protein kinase Chk2 | 2.7.11.1 | 0.441 | |
| 2x6d | X6D | Aurora kinase A | 2.7.11.1 | 0.441 | |
| 3cgf | JNF | Mitogen-activated protein kinase 10 | 2.7.11.24 | 0.441 | |
| 3d1y | ROC | Gag-Pol polyprotein | 3.4.23.16 | 0.441 | |
| 3gu6 | ADP | Death-associated protein kinase 1 | 2.7.11.1 | 0.441 | |
| 3nuu | JOZ | 3-phosphoinositide-dependent protein kinase 1 | 2.7.11.1 | 0.441 | |
| 3umw | 596 | Serine/threonine-protein kinase pim-1 | 2.7.11.1 | 0.441 | |
| 4bcm | T7Z | Cyclin-dependent kinase 2 | 2.7.11.22 | 0.441 | |
| 4dca | ADP | Aminoglycoside phosphotransferase | / | 0.441 | |
| 4flh | 14K | Phosphatidylinositol 4,5-bisphosphate 3-kinase catalytic subunit gamma isoform | 2.7.1.153 | 0.441 | |
| 4foc | 0UU | ALK tyrosine kinase receptor | 2.7.10.1 | 0.441 | |
| 4fux | E75 | Mitogen-activated protein kinase 1 | 2.7.11.24 | 0.441 | |
| 4gj2 | 0XH | Non-receptor tyrosine-protein kinase TYK2 | 2.7.10.2 | 0.441 | |
| 4mcv | 29K | Proto-oncogene tyrosine-protein kinase Src | 2.7.10.2 | 0.441 | |
| 4nka | 2K7 | Fibroblast growth factor receptor 1 | / | 0.441 | |
| 1daw | ANP | Casein kinase II subunit alpha | 2.7.11.1 | 0.440 | |
| 1k6v | XN2 | Gag-Pol polyprotein | 3.4.23.16 | 0.440 | |
| 1nxk | STU | MAP kinase-activated protein kinase 2 | 2.7.11.1 | 0.440 | |
| 1pjk | ANP | Casein kinase II subunit alpha | 2.7.11.1 | 0.440 | |
| 2aqu | DR7 | Gag-Pol polyprotein | 3.4.23.16 | 0.440 | |
| 2c6e | HPM | Aurora kinase A | 2.7.11.1 | 0.440 | |
| 2itt | AEE | Epidermal growth factor receptor | 2.7.10.1 | 0.440 | |
| 2iw6 | QQ2 | Cyclin-dependent kinase 2 | 2.7.11.22 | 0.440 | |
| 2nnp | ROC | Protease | / | 0.440 | |
| 2rio | ADP | Serine/threonine-protein kinase/endoribonuclease IRE1 | 2.7.11.1 | 0.440 | |
| 2ym4 | 4YM | Serine/threonine-protein kinase Chk1 | 2.7.11.1 | 0.440 | |
| 4ftt | 6HK | Serine/threonine-protein kinase Chk1 | 2.7.11.1 | 0.440 | |
| 4gih | 0X5 | Non-receptor tyrosine-protein kinase TYK2 | 2.7.10.2 | 0.440 | |
| 4ivd | 15T | Tyrosine-protein kinase JAK1 | / | 0.440 | |
| 4j5j | 478 | Gag-Pol polyprotein | 3.4.23.16 | 0.440 | |
| 4l9k | EHF | Serum albumin | / | 0.440 | |
| 4uym | VOR | 14-alpha sterol demethylase Cyp51B | / | 0.440 |